Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Discovery Laboratories Inc

+ Add to Watchlist

DSCO:US

1.2500 USD 0.0600 4.58%

As of 20:10:00 ET on 01/29/2015.

Company Profile for Discovery Laboratories Inc (DSCO)

Discovery Laboratories, Inc. is a biopharmaceutical company that develops its proprietary surfactant technology as Surfactant Replacement Therapies (SRT) for respiratory diseases. Through this technology, pulmonary surfactants have the potential to be developed into a series of respiratory therapies for patients in the neonatal care unit, critical care unit and other hospital settings.

Contact Information

Discovery Laboratories Inc

2600 Kelly Road
Suite 100
Warrington, PA 18976-3622
United States
Phone: 1-215-488-9300
Fax: 1-215-488-9301

Key Executives for Discovery Laboratories Inc (DSCO)

John G CooperPresident/CEOJohn A TattorySenior VP/CFO
Steven G SimonsonSenior VP/Chief Dev OfcrThomas F MillerSenior VP/COO
Mary B TempletonSenior VP/Secy/Gen CnslKathryn A ColeSenior VP:Human Resources
Lawrence WeinsteinVP:Medical Device DevelopmentThomas C HoyVP:Manufacturing Ops
William C RobertsVP:Investor RelationsMichael L MageeVP:Quality Operations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil